Celgene Corp. (CELG)

Sector:Health Care
Super Investor Stats:
Ownership count:0
Ownership rank:--
% of all portfolios:0%
History Portfolio Manager Activity ▼ Share change % change to portfolio
Q4  2019
≡ David Abrams - Abrams Capital Management Sell 100.00% 6,752,869 18.77
≡ David Rolfe - Wedgewood Partners Sell 100.00% 393,967 3.47
Q3  2019
≡ David Rolfe - Wedgewood Partners Reduce 9.07% 39,293 0.35
Q2  2019
≡ David Rolfe - Wedgewood Partners Reduce 17.50% 91,879 0.72
≡ Seth Klarman - Baupost Group Sell 100.00% 4,000,000 3.27
≡ Daniel Loeb - Third Point Sell 100.00% 1,750,000 1.85
≡ Bill Miller - Miller Value Partners Sell 100.00% 423,255 1.59
≡ Prem Watsa - Fairfax Financial Holdings Sell 100.00% 14,500 0.07
Q1  2019
≡ David Rolfe - Wedgewood Partners Reduce 19.78% 129,493 0.89
≡ Bill Miller - Miller Value Partners Reduce 49.38% 412,940 1.55
≡ Michael Burry - Scion Asset Management Sell 100.00% 45,000 2.79
Q4  2018
≡ David Rolfe - Wedgewood Partners Reduce 13.57% 102,742 0.44
Q3  2018
≡ David Rolfe - Wedgewood Partners Reduce 12.36% 106,862 0.48
Q2  2018
≡ David Rolfe - Wedgewood Partners Reduce 6.52% 60,306 0.24
Q1  2018
≡ David Rolfe - Wedgewood Partners Reduce 3.93% 37,776 0.15
≡ Thomas Russo - Gardner Russo & Quinn Sell 100.00% 500 0.00
Q3  2017
≡ David Rolfe - Wedgewood Partners Reduce 15.34% 122,626 0.61
≡ Lee Ainslie - Maverick Capital Sell 100.00% 19,150 0.03
Q2  2016
≡ Lee Ainslie - Maverick Capital Sell 100.00% 4,900 0.01
Q3  2015
≡ Lee Ainslie - Maverick Capital Reduce 6.28% 140 0.00

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.